AMGN stock news
This page provides real-time market news, earnings updates, and company announcements related to Amgen Inc. (AMGN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-13 12:01 EST
Amgen Leads Trading Activity Following Cancer Drug Partnership with Zai Lab
101 finance2026-04-01 22:39:58
CYCN Plunges 17% After Merger Announcement: What’s Next for Cyclerion and Korsana?
101 finance2026-04-02 14:19:08
Inovio Plummets 34.5%: Biotech's Volatile Move Sparks Market Alert
101 finance2026-04-02 14:37:00
Entera Bio (ENTX) Jumps 17.5% During the Day as Biotech Sector Sees Broad Gains
101 finance2026-04-02 14:37:10
Regeneron Drops More Than 2.9% During the Day: What’s Behind the Market Fluctuation?
101 finance2026-04-02 14:40:21
Elegrobart Faces Crucial Safety S-Curve Ahead of Q2 2026 REVEAL-2 Readout
101 finance2026-04-02 17:33:36
Amgen (AMGN) Shares Fall as Market Rises: What Investors Should Know
101 finance2026-04-02 22:54:44
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Finviz2026-04-06 13:03:55
ABVC BioPharma Surges 22.9% Intraday: What’s Fueling This Volatile Move?
101 finance2026-04-06 15:21:42
Rein Therapeutics Surges 24% Intraday: What's Driving This Biotech Breakout?
101 finance2026-04-06 16:40:12
AnaptysBio Jumps 8.5%: Biotech Turmoil Intensifies Amid Soaring Options Activity and Volatility
101 finance2026-04-06 19:33:51
The S&P 500 index preliminarily closed up 0.4%. The consumer discretionary sector rose 0.7%, consumer staples, financials, and energy sectors gained 0.6%, the technology sector increased 0.3%, while the healthcare sector fell 0.5%.
华尔街见闻2026-04-06 20:02:03
Investors Are Actively Looking Into Amgen Inc. (AMGN): Key Information You Should Be Aware Of
101 finance2026-04-07 14:03:49
AMGN’s Subcutaneous Tepezza Achieves Phase III Success in Treating Thyroid Eye Disease
101 finance2026-04-07 15:00:39
Silo Pharma's Patent Surge Driven by Behavioral Hype, Not Fundamentals
101 finance2026-04-07 16:21:42
CollPlant's Stock Collapses 20% Intraday—What’s Fueling This Freefall?
101 finance2026-04-07 19:18:35
Amgen (AMGN) Outperforms the Market: Key Points to Note
101 finance2026-04-09 23:00:54
Amgen's Tarlatamab China Approval: What's Priced In and What's Not
101 finance2026-04-10 08:39:43
Why Amgen (AMGN) is Likely to Surpass Earnings Expectations Once More
101 finance2026-04-10 17:15:55
Amgen Leads Market Turnover Despite Dip as MariTide Data Fuels Institutional Interest
101 finance2026-04-11 02:24:41
Is Overlooked Biotech Ready to Surge? Making the Argument for Platform Strategies in a Shifting Industry
101 finance2026-04-11 04:57:44
Neurocrine’s $2.9B Vykat XR Buy: A Rare Disease Firepower Grab With $2B+ Growth Already in Motion
101 finance2026-04-12 00:30:47
Viridian's Decline Misses Crucial Imbalance: Advantage in Safety and Brand Loyalty Compared to Amgen’s Latest Subcutaneous Standard
101 finance2026-04-12 20:36:45
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
Finviz2026-04-13 12:33:40
Regeneron Drops More Than 2.9% During the Day: What’s Behind the Market Fluctuation?
101 finance2026-04-02 14:40:21
Elegrobart Faces Crucial Safety S-Curve Ahead of Q2 2026 REVEAL-2 Readout
101 finance2026-04-02 17:33:36
Amgen (AMGN) Shares Fall as Market Rises: What Investors Should Know
101 finance2026-04-02 22:54:44
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Finviz2026-04-06 13:03:55
ABVC BioPharma Surges 22.9% Intraday: What’s Fueling This Volatile Move?
101 finance2026-04-06 15:21:42
Rein Therapeutics Surges 24% Intraday: What's Driving This Biotech Breakout?
101 finance2026-04-06 16:40:12
AnaptysBio Jumps 8.5%: Biotech Turmoil Intensifies Amid Soaring Options Activity and Volatility
101 finance2026-04-06 19:33:51
The S&P 500 index preliminarily closed up 0.4%. The consumer discretionary sector rose 0.7%, consumer staples, financials, and energy sectors gained 0.6%, the technology sector increased 0.3%, while the healthcare sector fell 0.5%.
华尔街见闻2026-04-06 20:02:03
Investors Are Actively Looking Into Amgen Inc. (AMGN): Key Information You Should Be Aware Of
101 finance2026-04-07 14:03:49
AMGN’s Subcutaneous Tepezza Achieves Phase III Success in Treating Thyroid Eye Disease
101 finance2026-04-07 15:00:39
Silo Pharma's Patent Surge Driven by Behavioral Hype, Not Fundamentals
101 finance2026-04-07 16:21:42
CollPlant's Stock Collapses 20% Intraday—What’s Fueling This Freefall?
101 finance2026-04-07 19:18:35
Amgen (AMGN) Outperforms the Market: Key Points to Note
101 finance2026-04-09 23:00:54
Amgen's Tarlatamab China Approval: What's Priced In and What's Not
101 finance2026-04-10 08:39:43
Why Amgen (AMGN) is Likely to Surpass Earnings Expectations Once More
101 finance2026-04-10 17:15:55
Amgen Leads Market Turnover Despite Dip as MariTide Data Fuels Institutional Interest
101 finance2026-04-11 02:24:41
Is Overlooked Biotech Ready to Surge? Making the Argument for Platform Strategies in a Shifting Industry
101 finance2026-04-11 04:57:44
Neurocrine’s $2.9B Vykat XR Buy: A Rare Disease Firepower Grab With $2B+ Growth Already in Motion
101 finance2026-04-12 00:30:47
Viridian's Decline Misses Crucial Imbalance: Advantage in Safety and Brand Loyalty Compared to Amgen’s Latest Subcutaneous Standard
101 finance2026-04-12 20:36:45
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
Finviz2026-04-13 12:33:40
AMGN stock chart
AMGN stock detailsAMGN stock price change
On the last trading day, AMGN stock closed at 351.02 USD, with a price change of -1.29% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more